Status:
UNKNOWN
FSH Followed by HMG vs FSH Plus HMG in IVF
Lead Sponsor:
Mansoura University
Conditions:
IVF
Eligibility:
FEMALE
20-37 years
Phase:
PHASE4
Brief Summary
The aim of this study is to compare the clinical outcomes of sequential administration of FSH and HP-hMG FSH alone versus concomitant administration of FSH and HP-hMG during controlled ovarian stimula...
Detailed Description
Women who are planned to be subjected to IVF/ICSI through COS by long GnRHa protocol will be assessed for possibility of participation in our study. Eligible participants in our study will be those wi...
Eligibility Criteria
Inclusion
- Women who are planned to be subjected to IVF/ICSI through COS by long GnRHa protocol.
- Women with regular menstrual cycle (21-35 days) and normal uterine anatomy (confirmed by transvaginal ultrasound examination and in some cases hysteronsalpingography and hysteroscopy).
Exclusion
- Age \< 20 or \> 37 years.
- Body mass index (BMI) \< 18 or \> 30 kg/m2.
- Low ovarian reserve (AFC \< 7 and/or AMH \< 1.1 ng/ml).
- Presence of polycystic ovarian syndrome (PCOS).
- Endometrioma or hydrosalpinx.
- History of chemotherapy, radiotherapy or ovarian surgery.
- The husband needs testicular biopsy to obtain sperm.
- Previous implantation failure.
Key Trial Info
Start Date :
June 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2022
Estimated Enrollment :
530 Patients enrolled
Trial Details
Trial ID
NCT04385342
Start Date
June 30 2020
End Date
August 31 2022
Last Update
June 9 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Fertility Care Unit (FCU) in Mansoura University Hospital
Al Mansurah, Dakahlia Governorate, Egypt, 35111
2
Department of Obstetrics and Gynecology
Alexandria, Egypt
3
RAHEM Fertility Centre
Zagazig, Egypt